RxDoctor Payments Data

James Bridgeman

Family Medicine · Greenville, SCNPI 1700811593

Payments from drug & device makers

$13,375in general payments, 2019–2025

Across 866 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Pfizer$843
  • AstraZeneca$824
  • Amgen$634
  • plus $6K from 51 others

What the payments were for

  • Consulting fees$1751%
  • Food & beverage$13,18399%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)161$2,009
Novo Nordisk122$1,661
Lilly USA, LLC78$1,003
Pfizer62$843
AstraZeneca44$824
Amgen(2 entities)36$634
Bayer35$489
Abbott23$439
Lundbeck LLC20$403
GSK27$397
Astellas Pharma US Inc21$367
Exact Sciences16$348
Dexcom, Inc.17$296
Johnson & Johnson13$292
Amarin Pharma, Inc.12$283
Esperion Therapeutics, Inc.12$265
Takeda Pharmaceuticals U.S.A., Inc.15$258
Sanofi-aventis U.S. LLC16$229
Boehringer Ingelheim15$227
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$215
Daiichi Sankyo Inc.11$208
Novartis11$184
Sunovion Pharmaceuticals Inc.2$131
Merck8$121
Axsome Therapeutics, Inc.6$107
Gilead7$90
Eisai Inc.4$81
Boston Scientific5$80
Paratek Pharmaceuticals, Inc.4$74
E.r. Squibb & Sons, L.L.C.5$70
Kowa Pharmaceuticals America, Inc.3$63
Idorsia Pharmaceuticals US Inc4$62
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$61
Scilex Pharmaceuticals Inc.3$57
Phathom Pharmaceuticals, Inc.4$56
Corium, LLC3$50
Hikma Pharmaceuticals USA3$41
Shield Therapeutics Inc2$34
Antares Pharma, Inc.2$30
Medtronic1$23
Vanda Pharmaceuticals Inc.1$22
Ultragenyx Pharmaceutical Inc.1$21
Clarus Therapeutics Inc.2$21
Azurity Pharmaceuticals, Inc.1$19
Upsher-smith Laboratories LLC1$17
Nevro Corp.1$17
Arbor Pharmaceuticals, Inc.1$17
Supernus Pharmaceuticals, Inc.1$16
Biohaven Pharmaceutical Holding Company Ltd.1$16
Inspire Medical Systems, Inc.1$15
VBI Vaccine (delaware) Inc.1$14
Eyevance Pharmaceuticals LLC1$14
Avanir Pharmaceuticals, Inc.1$14
Ironshore Pharmaceuticals Inc.1$13
Currax Pharmaceuticals LLC1$13
Sanofi Pasteur Inc.1$12
IBSA Pharma Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,375 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$165,429
Medicare patients
373
Services billed
4,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide104$143,959
EliquisApixaban73$113,984
OzempicSemaglutide65$97,911
JardianceEmpagliflozin52$73,870
XareltoRivaroxaban26$37,065
FarxigaDapagliflozin Propanediol31$34,369
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$31,934
Tresiba Flextouch U-200Insulin Degludec11$19,261
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$16,585
Janumet XrSitagliptin Phos/Metformin Hcl19$15,616
Tresiba Flextouch U-100Insulin Degludec20$13,991
Repatha SureclickEvolocumab16$12,632
Esomeprazole Magnesium94$8,527
Olmesartan Medoxomil402$8,409
Breo ElliptaFluticasone/Vilanterol20$7,265

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,003$143,959104 claims
PfizerEliquis$843$113,98473 claims
Novo NordiskOzempic$1,661$97,91165 claims
Boehringer IngelheimJardiance$227$73,87052 claims
GSKTrelegy Ellipta, Breo Ellipta$397$39,19941 claims
AstraZenecaFarxiga, Symbicort$824$39,04143 claims
Johnson & JohnsonXarelto$292$37,06526 claims
MerckJanumet Xr$121$15,61619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →